Turk Ilac Ve Serum Sanayi Anonim Sirketi reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TRY 347.91 million compared to TRY 623.21 million a year ago. Sales was TRY 347.91 million compared to TRY 623.21 million a year ago.

Net loss was TRY 27.48 million compared to net income of TRY 59.92 million a year ago. Net loss was TRY 27.48 million compared to net income of TRY 59.92 million a year ago. Basic loss per share from continuing operations was TRY 0.17 compared to basic earnings per share from continuing operations of TRY 0.37 a year ago.